NCT06840041

Brief Summary

The goal of this observational study is to investigate the relationship between vaginal microbiota composition and the development of post-cesarean section wound infection in women undergoing cesarean delivery. The main question it aims to answer is: Is there a correlation between specific vaginal microbiota profiles and the incidence of post-cesarean section wound infection? Can specific bacterial taxa or diversity indices within the vaginal microbiota predict the risk of post-cesarean section wound infection? Participants will: Provide vaginal swab samples pre-operatively and post-operatively. Undergo standard post-cesarean section care and follow-up. Have wound assessment performed per standard of care, and have data collected regarding wound infection status. Have demographic and clinical data collected, including but not limited to, antibiotic use, gestational age, and comorbidities.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

February 18, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 21, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

June 30, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

February 18, 2025

Last Update Submit

June 13, 2025

Conditions

Keywords

cesarean sectionSSIvaginal microbiota

Outcome Measures

Primary Outcomes (1)

  • Comparison of Vaginal Microbiota Composition and Surgical Site Infection (SSI) Incidence

    This outcome will assess the differences in vaginal microbiota composition between women who develop a surgical site infection (SSI) following cesarean section and those who do not. Microbiota composition will be determined through culture and analysis of vaginal swab samples collected pre-operatively and post-operatively. Comparisons will focus on identifying significant variations in bacterial taxa, diversity indices, and overall microbial community structure between the two groups.

    4 weeks after the surgery.

Secondary Outcomes (1)

  • Predictive Value of Specific Vaginal Bacterial Species for Surgical Site Infection (SSI).

    6 months

Study Arms (1)

cesarean section group

This observational study will enroll 160 women undergoing cesarean section. Participants will provide vaginal swab samples for culture, both pre-operatively and post-operatively. They will be monitored post-operatively for the development of wound infections, with wound assessments performed according to standard clinical practice. Demographic and clinical data, including antibiotic use, gestational age, and comorbidities, will be collected to assess the relationship between vaginal microbiota and post-cesarean wound infections.

Diagnostic Test: Vaginal swab and culture

Interventions

Participants will undergo vaginal swab collection both pre-operatively, immediately prior to the cesarean section, and post-operatively, within a defined timeframe after the procedure. The swabs will be collected using sterile swabs, following standardized procedures to ensure accurate sampling of the vaginal microbiota. The collected samples will then be sent to a designated laboratory for culture and analysis. This process will identify and characterize the bacterial composition of the vaginal microbiota, allowing researchers to investigate potential correlations between specific microbial profiles and the development of post-cesarean section wound infections

cesarean section group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study is exclusively for female participants undergoing cesarean section. Biological females are the only eligible participants due to the focus on vaginal microbiota and its relationship to post-cesarean section wound infections.
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

This study will enroll pregnant women undergoing either elective or emergency cesarean section at or beyond 37 weeks of gestation. Participants must have a singleton pregnancy. Women with known immunodeficiency, chronic infections, or those who have received antibiotics within two weeks prior to delivery will be excluded. Additionally, women with ruptured membranes for more than 18 hours will be excluded to minimize the potential influence of prolonged exposure to mixed flora. The study aims to investigate the relationship between vaginal microbiota and post-cesarean section wound infection within this defined population.

You may qualify if:

  • Pregnant women undergoing elective or emergency cesarean section (CS).
  • Singleton pregnancy.
  • Cesarean section performed at ≥ 37 weeks of gestation.

You may not qualify if:

  • Use of antibiotics within two weeks prior to delivery.
  • Known immunodeficiency.
  • Chronic infections.
  • Ruptured membranes for more than 18 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Hussein University Hospital

Cairo, 11633, Egypt

Location

MeSH Terms

Conditions

Wounds and InjuriesInfections

Study Officials

  • Muhamed Alhagrasy

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhamed Alhagrasy, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer and consultant at Obstetrics and Gynecology Department.

Study Record Dates

First Submitted

February 18, 2025

First Posted

February 21, 2025

Study Start

June 30, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

June 15, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

De-identified Individual Participant Data (IPD) that underlie the results reported in this article, including study protocol, statistical analysis plan, and analytic code, will be made available upon reasonable request to qualified researchers after publication. Requests should be submitted to MuhamedAhmed.216@azhar.edu.eg. Proposals will be reviewed by the Department of Obstetrics and Gynecology, Al-Azhar University to ensure that the proposed use of the data is scientifically sound and ethical. Data will be shared in a secure, password-protected format, and a data sharing agreement will be required to ensure responsible use and protection of participant confidentiality. The data will be available for 5 years following publication. Publication of results will be made without identifiers

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
5 years after publication.
Access Criteria
Access to de-identified Individual Participant Data (IPD) will be granted to qualified researchers with a demonstrated scientific need and a clearly defined research question. Researchers must submit a formal request to MuhamedAhmed.216@azhar.edu.eg, outlining their research proposal, including the specific data requested, the intended use of the data, and their qualifications. Requests will be reviewed by the Department of Obstetrics and Gynecology, Al-Azhar University to ensure scientific merit and ethical compliance. Researchers must agree to sign a data sharing agreement that outlines the terms of data use, including restrictions on redistribution and requirements for appropriate data security and confidentiality.

Locations